Work for Eiger BioPharmaceuticals, Inc. ?

Claim Your Profile

Eiger BioPharmaceuticals, Inc.  Logo Image

Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.  Banner Image

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

2019 Annual Report and Form 10K

Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc. has reached its limit for free report views.

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

Archived Annual Reports

About Eiger BioPharmaceuticals, Inc.

11-50 Employees
Based in Palo Alto, California

Eiger is a biopharmaceutical company focused on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. Eiger's pipeline includes preclinical NCEs from discovery as well repurposed clinical Rx agents shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses. http://www.eigerbio.com

Ticker:
EIGR
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol